News and Announcements
Ai-Media Share Price Up by 20%, New 5-Year Contract with Channel 7 & Featured on USA Today, Techcrunch, Sky News & More
- Published August 08, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Ai-Media delivers live & offline television captioning under long term contracts for many Foxtel channels, education captioning for schools and universities, and high quality transcripts to 99.90% accuracy for government and corporate clients.
- Share price increase over the last 12 months by 20%
- New additions to staff, Board or Management as follows: Mark A. Phillips – President of Ai-Media Inc (US), Alison Loat – Board Chair of Ai-Media Canada Inc
- New 5-year contract with Channel 7.
- Partnership with Facebook to launch captions on Facebook Live (June 2017)
- New product of Facebook Live captions (world-first)
- 4 consecutive quarters of 99.6% quality for live captioning audit. Continued development and growth of Visible Classroom app.
Captions for F8 (Facebook Developers Conference), and for 21 organisations at United Nations (Conference of the States Parties to the Convention on the Rights of Persons with Disabilities (New York), plus captioning at UN Regional Conferences (eg Turkey), Zero (UN conference in Vienna), Association on Higher Education and Disability (Orlando), Guelph Accessibility Conference (Canada)
Facebook blog noting Ai-Media as their partner with the launch.
Coverage including USA Today, Techcrunch, our Facebook launch video.
Sky News interview.
Facebook Live interview with Prime Minister, Malcolm Turnbull.
Interview with ABC’s Marc Fennell.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
